| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |